Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lamotrigine as Treatment of Myotonia - a Phase 3 Randomized Controlled Trial Study

NCT01939561 is registered in ClinicalTrials.gov with Grete Andersen, MD as lead sponsor.

NCT NCT01939561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01939561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lamotrigine as Treatment of Myotonia - a Phase 3 Randomized Controlled Trial Study
Lead sponsor
Grete Andersen, MD
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2013
Completion date
November 30, 2015
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dystrophia myotonica type 1, hyperkalemic periodic paralysis, myotonia congenita, paramyotonia congenita, potassium-aggravated myotonia